Login / Signup

Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.

Daniel ReJérôme BarrièreEmmanuel ChamoreyMargaux DelforgeLauris GastaudEmmanuel PetitAxel ChaminadeBenjamin VerrièreFrédéric Peyrade
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • binding protein
  • coronavirus disease